Compugroup Medical (ETR:COP) has been given a €60.00 ($69.77) price target by stock analysts at HSBC in a research note issued to investors on Tuesday. The brokerage currently has a “buy” rating on the stock. HSBC’s target price would indicate a potential upside of 10.91% from the stock’s previous close.
COP has been the topic of several other research reports. Hauck & Aufhaeuser set a €40.00 ($46.51) target price on Compugroup Medical and gave the stock a “sell” rating in a research note on Tuesday, February 5th. Baader Bank set a €49.00 ($56.98) target price on Compugroup Medical and gave the stock a “buy” rating in a research note on Monday, February 4th. Deutsche Bank set a €63.00 ($73.26) target price on Compugroup Medical and gave the stock a “buy” rating in a research note on Friday, February 8th. Finally, Warburg Research set a €53.50 ($62.21) target price on Compugroup Medical and gave the stock a “buy” rating in a research note on Monday, February 4th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating to the company’s stock. Compugroup Medical currently has a consensus rating of “Hold” and a consensus target price of €53.07 ($61.71).
COP traded up €2.35 ($2.73) during mid-day trading on Tuesday, hitting €54.10 ($62.91). 107,928 shares of the stock were exchanged, compared to its average volume of 68,245. Compugroup Medical has a 1-year low of €37.64 ($43.77) and a 1-year high of €54.15 ($62.97). The company has a current ratio of 1.13, a quick ratio of 0.92 and a debt-to-equity ratio of 121.58. The firm has a market cap of $2.68 billion and a price-to-earnings ratio of 31.64.
CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. The company's Ambulatory Information Systems segment provides practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician's networks.
Read More: What is Call Option Volume?
Receive News & Ratings for Compugroup Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical and related companies with MarketBeat.com's FREE daily email newsletter.